CTOs on the Move

Sarah Bush Lincoln

www.sarahbush.org

 
Sarah Bush Lincoln Health Center is a 129-bed, not-for-profit, regional hospital centrally located in East Central Illinois Coles County, and is the recipient of the 2011 Illinois Performance Excellence Gold Award for Achievement of Excellence, the highest performance honors in the state. Sarah Bush Lincoln is accredited by The Joint Commission, the nations oldest and largest standards-setting and accrediting body in healthcare. The Health Center provides a full range of acute care services to residents of Coles County and the surrounding eight counties. Home health services extend to the surroundings 19 counties in East Central and Southern Illinois. Active and ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.sarahbush.org
  • 1000 Health Center Drive
    Mattoon, IL USA 61938
  • Phone: 217.258.2525

Executives

Name Title Contact Details

Similar Companies

Immunization for Public Health (i4ph)

Immunization for Public Health (i4ph) is a Galveston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Charlottesville Medical Research

Charlottesville Medical Research is a Charlottesville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Suncrest Hospice

Suncrest Care is a company that provides home health and hospice care services with a mission to provide the highest quality of care and customer service to patients, their families, and referring sources.

DayTwo

Covers a range of chronic conditions— impacting over 50% of employees Type 2 DiabetesPrediabetesClinical ObesityNAFLD

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.